Navigation Links
Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
Date:12/3/2009

matters discussed in this press release are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. For example, there can be no assurance that the U.S. Food and Drug Administration will grant marketing clearance of the ExcellagenXL(TM) and ExcellagenFX(TM) product candidates or that we can successfully introduce these or additional products into advanced wound care markets; that Excellagen, Excellarate or our other candidates will prove to be sufficiently safe and effective, or that results or trends observed in one clinical study or procedure will be reproduced in subsequent studies or procedures, or that clinical studies even if successful will lead to product advancement or partnering; that the Excellagen or Excellarate product candidate offers the potential for simpler or more cost-effective treatment for physicians and patients than other FDA-approved products that currently are or will be on the market; that the Matrix clinical study program or other human clinical trials can be conducted and completed in an efficient and successful manner; that we can develop a DNA-based orthobiologics product portfolio; that our products or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive; that FDA or other regulatory clearances or other certifications, or other commercialization efforts will be successful or will effectively enhance our businesses or their market value; that our products or product candidates will prove to be sufficiently safe and effective after introduction into a broader patient population; or that third parties on whom we depend will perform as anticipated.

Actual results may also differ substantially from those described in or contemplated by this press release due to
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
2. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
3. Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
4. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
7. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
8. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
9. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
10. Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
11. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... and VANCOUVER, British Columbia ... OGXI ) announced today that it will report ... 14, 2015. Company management will host a conference call ... provide an overview of financial results, clinical development programs ... access the webcast, log on to the Investor Relations ...
(Date:5/4/2015)... 2015 PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... the first quarter ending March 31, 2015. ... our first full quarter since the commercial launch, we have ... for nonsense mutation Duchene Muscular Dystrophy. We now have 82 ... since our last earnings call," stated Stuart W. Peltz ...
(Date:5/4/2015)... BEACH, Va. , May 4, 2015 /PRNewswire/ ... investment company focused on the lower middle market, ... Inc. ("BMS").  Founded in 1969 and based in ... provides a full range of radiation products for ... Fox Three partnered with Peninsula Capital Partners ("Peninsula"), ...
Breaking Medicine Technology:PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 9Fox Three Partners, LLC Acquires Burlington Medical Supplies, Inc. 2
... , Study shows 4% CHG antiseptic is effective against a ... Ga., June 24 Hand washing with a 4% chlorhexidine ... to stop the spread of the H1N1 Swine Flu Virus. ... Personnel Hand Antiseptic Towelettes have been tested and found to ...
... Jude study shows personalized chemotherapy can improve cure rate ... leukemia treatment , , MEMPHIS, Tenn., June ... can be successfully treated using a carefully personalized chemotherapy ... Research Hospital have found. Such radiation of the brain ...
Cached Medicine Technology:Hand Washing with 4% CHG Antiseptic Kills Flu Viruses 2Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation 2Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation 3Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation 4
(Date:5/4/2015)... Milton Hershey School® has named J. ... the Year, recognizing his commitment to pediatric cancer research ... for MHS students. , “Dr. Graves is a tremendous ... are provided a top-notch education, a nurturing environment, and ... Pete Gurt ’85, president of MHS. “He is applying ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 McNeil ... programs, announces the expansion of coverage for its ... leading provider of industry-tailored insurance and proactive risk management ... Company, we are dedicated to providing our customers with ... their many evolving needs. We are excited to launch ...
(Date:5/4/2015)... “ LiveSchool ” was featured on NewsWatch ... look at the latest and coolest applications on the ... host of AppWatch and technology expert, conducted the app ... teachers to reward students with good behavior. , Positive ... the classroom. And the good people at LiveSchool ...
(Date:5/4/2015)... The American Telemedicine Association (ATA) today released ... identify gaps in coverage and reimbursement, and physician practice ... Telemedicine Gaps Reports last September, many state regulating bodies ... impact healthcare delivery in their state,” said Jonathan Linkous, ... across the nation, ATA reevaluated the indicators for each ...
(Date:5/4/2015)... 04, 2015 In May of 2010, after ... own life. In the wake of this tragedy, Ty’s parents ... organization that exposes the grim reality of bullying and its ... for Kirk and Laura to share their story and offer ... happening to another family — a mission that took the ...
Breaking Medicine News(10 mins):Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 3
... more likely to suffer from behavioural problems, a major ... hormone not only boosted growth in children, but also ... researcher Dr Derick Beens, professor of psychiatry and pediatrics ... this work demonstrates that all very short children need ...
... cause women to have smaller babies, researchers have discovered. ... flow through the arteries that feed the uterus. Doctors ... studied 200 expectant mothers. ,They found pregnant ... abnormal patterns of blood flow through the uterine arteries". ...
... the risk of heart problems for diabetic patients.Tiny particles ... known to cause both respiratory and heart problems. Researchers ... County Illinois for 1988 to 1994 and have uncovered ... people with diabetes.// ,PM10s increase the risk ...
... high doses of iron are more responsive to infection. Iron is ... cells and iron deficiency is a relatively common health problem ... That is why many breakfast cereals are now fortified with iron, ... ,But too much iron might be as bad for you ...
... depression worsens the outlook in heart disease.,Mounting evidence suggests a ... School of Medicine now have a new clue as to ... your heart. They followed a subset of participants in the ... the outcome of a large number of heart attack patients ...
... weapons go, anthrax is nowhere as terrifying as several others, ... University. Smallpox would be a lot worse. The government now ... Experiments are getting underway to see whether it can be ... still be effective. // ,“Anthrax is not ...
Cached Medicine News:Health News:Avoid stress to have strong babies 2
Fahlbusch hypophysectomie instrument, spoon, bayonet-shaped, malleable....
... is pouncing on the T.L.I.F. market as the ... of CFRP clinical history and the amazing success ... Leopard is sure to be king of the ... from 7-18 mm in height. The footprint is ...
... Cage System provides anterior column support for ... from T1 to L5. The system consists ... Polymer cages that are stacked to a ... Peek Carbon Fiber Reinforced Polymer material emulates ...
... Jaguar Lumbar I/F Cage system is a ... separate the mechanical and biologic functions of ... Lumbar I/F Cage provides a device designed ... and uses autologous cancellous bone, the best ...
Medicine Products: